澳大利亚TGA:未来或将有更多本土注册的青霉素钠注射剂品牌上市

美股速递
May 27

澳大利亚治疗商品管理局(TGA)表示,未来市场上有望出现更多在澳大利亚注册的替代性青霉素钠注射剂品牌。这一预期旨在增加关键抗生素的供应来源,提升医疗系统的药品可及性与选择多样性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10